Alkem Labs hit with FDA 483 with three observations at Indian plant 13-Mar-2017 By Dan Stanton The US FDA has issued a Form 483 with three observations to Alkem Laboratories after an inspection at its facility in Himachal Pradesh, India.
ManKind plans to build manufacturing plant in the Himalayas 30-Nov-2015 By Gareth Macdonald ManKind Pharma plans to set up manufacturing facilities in Northeast India to bring production in-house and cut its tax bill.
Torrent acquires Indian dermatological drugmaker Zyg 20-Jul-2015 By Dan Stanton Torrent Pharma has added two facilities to its network through the acqusition of Zyg Pharma from the Encore Group.
Indian state regulator suspends manufacture of drug at Wockhardt plant 24-Apr-2014 By Dan Stanton Indian authorities have suspended the manufacture of a Wockhardt fixed dose combination drug, the company has announced in a filing.
India claims 40% drop in fake drugs despite uptick in testing 02-Apr-2012 By Nick Taylor The number of fake or adulterated drugs found in India fell 40 per cent from 2008 to 2010 despite an uptick in testing, government data claims.
